SELLAS Life Sciences Group, Inc. (SLS)

SELLAS Life Sciences Group, Inc. (SLS) is a healthcare company (biotechnology) based in the United States. The share price is $20.40, up 173.09% on the day, which values the company at $4.16B. Price as of 17 Nov 2026, 17:27 UTC, from Yahoo Finance.

Key facts

Share price
$20.40+173.09% today
Market value
$4.16B
200-week average
$3.11556% above
Sector
Healthcare

Figures as of . Prices from Yahoo Finance (may be delayed); statements from company filings with the SEC and Yahoo Finance. Estimates, not advice.

SELLAS Life Sciences Group, Inc. in more detail

SLS trades at -214.7× next year's expected earnings. It sits 556% above its 200-week average of $3.11.

In its favour: More cash than debt. Worth checking: Weak Piotroski score; Share count keeps rising.

1 of the superinvestors tracked here hold SLS, including Polen Capital team (0.0% of the portfolio).

Superinvestors holding SLS

1 of the investors tracked here report a position in their latest 13F filing.

SELLAS Life Sciences Group, Inc. (SLS): questions and answers

What is SELLAS Life Sciences Group, Inc.'s market cap?

SELLAS Life Sciences Group, Inc. is valued at $4.16B at a share price of $20.40.

Is SLS above its 200-week moving average?

Yes. SLS is 555.6% above its 200-week average of $3.11. Long-term investors watch that line because strong companies rarely trade below it for long.

Does SLS pay a dividend?

SELLAS Life Sciences Group, Inc. does not currently pay a regular dividend.

Which famous investors own SLS?

In their latest quarterly filings, Polen Capital team (0.0% of the portfolio) hold SLS. These filings are published up to 45 days after each quarter ends, so positions may have changed since.

Cite this page

Funkfolio, “SELLAS Life Sciences Group, Inc. (SLS) stock: price, valuation and fundamentals”, data as of 17 November 2026. https://funkfolio.com/stock/SLS

Underlying data: Yahoo Finance; company filings with the SEC.